(FLN) First Trust Latin America - Ratings and Ratios
Latin America, Equities, Emerging Markets, AlphaDEX, Stock, ETF
Description: FLN First Trust Latin America
The First Trust Latin America AlphaDEX® Fund (NASDAQ:FLN) is an actively managed ETF that focuses on capturing alpha, or excess returns, from Latin American stocks. By utilizing the AlphaDEX® methodology, the funds index selects securities from the NASDAQ Latin America Index that exhibit potential for outperforming traditional market-cap weighted indices on a risk-adjusted basis.
The AlphaDEX® strategy is a rules-based approach that evaluates stocks based on various fundamental and quantitative factors, aiming to identify those with the highest potential for positive alpha. This methodology is designed to tilt the portfolio towards stocks that are more likely to outperform, rather than simply tracking a market-cap weighted index. As a result, FLN offers investors a unique exposure to Latin American equities, with a focus on capturing excess returns.
From a technical analysis perspective, FLNs price action suggests a bullish trend, with the ETF trading above its 20-day, 50-day, and 200-day moving averages. The Average True Range (ATR) indicates a moderate level of volatility, which may be expected given the ETFs focus on Latin American markets. With a 52-week high of $19.34 and a low of $14.94, FLN has demonstrated significant price movement in the past year.
Combining technical and fundamental insights, a forecast for FLN can be derived. With the ETFs AUM of $12.21M USD and its focus on capturing alpha, FLN is well-positioned to benefit from any upswing in Latin American markets. Given the current technical trends, a potential target price for FLN could be around $20.50, representing a 6% increase from its current price. However, this is contingent upon the ETFs ability to maintain its bullish trend and the overall performance of the underlying Latin American stocks.
Its worth noting that investors should be aware of the potential risks associated with investing in emerging markets, such as those in Latin America. These risks include currency fluctuations, economic instability, and regulatory challenges. As with any investment, its essential to conduct thorough research and consider multiple perspectives before making a decision.
Additional Sources for FLN ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
FLN ETF Overview
Market Cap in USD | 13m |
Category | Latin America Stock |
TER | 0.80% |
IPO / Inception | 2011-04-18 |
FLN ETF Ratings
Growth Rating | 50.7 |
Fundamental | - |
Dividend Rating | 59.6 |
Rel. Strength | 3.95 |
Analysts | - |
Fair Price Momentum | 20.26 USD |
Fair Price DCF | - |
FLN Dividends
Dividend Yield 12m | 4.04% |
Yield on Cost 5y | 6.22% |
Annual Growth 5y | 24.57% |
Payout Consistency | 74.6% |
Payout Ratio | % |
FLN Growth Ratios
Growth Correlation 3m | 95.7% |
Growth Correlation 12m | 23.5% |
Growth Correlation 5y | 73.8% |
CAGR 5y | 10.97% |
CAGR/Max DD 5y | 0.42 |
Sharpe Ratio 12m | 1.52 |
Alpha | 8.20 |
Beta | 0.488 |
Volatility | 17.65% |
Current Volume | 6.6k |
Average Volume 20d | 2.9k |
As of July 05, 2025, the stock is trading at USD 20.33 with a total of 6,600 shares traded.
Over the past week, the price has changed by +3.94%, over one month by +7.66%, over three months by +24.13% and over the past year by +17.19%.
Partly, yes. Based on ValueRay´s Analyses, First Trust Latin America (NASDAQ:FLN) is currently (July 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 50.72 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of FLN is around 20.26 USD . This means that FLN is currently overvalued and has a potential downside of -0.34%.
First Trust Latin America has no consensus analysts rating.
According to our own proprietary Forecast Model, FLN First Trust Latin America will be worth about 22.7 in July 2026. The stock is currently trading at 20.33. This means that the stock has a potential upside of +11.81%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 22.7 | 11.8% |